Stifel Financial Corp Viking Therapeutics, Inc. Transaction History

Stifel Financial Corp

$85.8 Billion
Q1 2024

A detailed history of Stifel Financial Corp transactions in Viking Therapeutics, Inc. stock. As of the latest transaction made, Stifel Financial Corp holds 23,881 shares of VKTX stock, worth $1.23 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

23,881

Previous 10,237 133.28%

Holding current value

$1.23 Million

Previous $190,000 930.53%

% of portfolio

0.0%

Previous 0.0%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 13, 2024	BUY	$17.4 - $94.5 $237,405 - $1.29 Million	13,644 Added 133.28%	23,881 $1.96 Million
Q4 2023 Feb 12, 2024	BUY	$9.24 - $19.64 $94,589 - $201,054	10,237 New	10,237 $190,000
Q4 2021 Feb 14, 2022	SELL	$4.6 - $6.72 $95,523 - $139,547	-20,766 Closed	0 $0
Q3 2021 Nov 15, 2021	SELL	$5.58 - $7.04 $558 - $704	-100 Reduced 0.48%	20,766 $130,000
Q2 2021 Aug 13, 2021	SELL	$5.19 - $6.73 $49,003 - $63,544	-9,442 Reduced 31.15%	20,866 $125,000

Q1 2021 May 14, 2021	BUY	$5.74 - $9.67 $61,280 - $103,236	10,676 Added 54.38%	30,308 $192,000
Q4 2020 Feb 12, 2021	SELL	$5.3 - $6.71 $4,144 - $5,247	-782 Reduced 3.83%	19,632 $111,000
Q3 2020 Nov 16, 2020	BUY	$5.73 - $8.11 $3,947 - $5,587	689 Added 3.49%	20,414 $119,000
Q2 2020 Aug 14, 2020	SELL	$4.35 - $8.08 $4,967 - $9,227	-1,142 Reduced 5.47%	19,725 $142,000
Q1 2020 May 14, 2020	SELL	$3.45 - $7.95 $48,255 - $111,196	-13,987 Reduced 40.13%	20,867 $99,000
Q4 2019 Feb 13, 2020	BUY	$6.38 - $8.73 $82,882 - $113,411	12,991 Added 59.42%	34,854 $290,000
Q3 2019 Nov 13, 2019	SELL	$6.55 - $8.6 $2,161 - $2,838	-330 Reduced 1.49%	21,863 $162,000
Q2 2019 Aug 14, 2019	SELL	$7.67 - $10.63 $4,778 - $6,622	-623 Reduced 2.73%	22,193 $189,000
Q1 2019 May 14, 2019	BUY	$7.58 - $9.94 $3,805 - $4,989	502 Added 2.25%	22,816 $233,000
Q4 2018 Feb 13, 2019	BUY	$7.16 - $16.21 $37,496 - $84,891	5,237 Added 30.67%	22,314 $176,000
Q3 2018 Nov 13, 2018	SELL	$9.7 - $19.65 $96,786 - $196,067	-9,978 Reduced 36.88%	17,077 $298,000
Q2 2018 Aug 14, 2018	BUY	$3.88 - $12.74 $104,973 - $344,680	27,055 New	27,055 $258,000

Others Institutions Holding VKTX

# of Institutions

426

Shares Held

63.1M

Call Options Held

7.39M

Put Options Held

5.13M

View Full List

About Viking Therapeutics, Inc.

Ticker VKTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 76,688,496
Market Cap $3.95B
Description
Viking Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development of novel therapies for metabolic and endocrine disorders. The company's lead drug candidate is VK2809, an orally available tissue and receptor-subtype selective agonist of the thyroid hormone receptor beta (TRß), which is in Phase IIb clinical trial...

More about VKTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Stifel Financial Corp, based on Form 13F filings with the SEC.

News

Stay updated on Stifel Financial Corp with notifications on news.

Account

Stifel Financial Corp Viking Therapeutics, Inc. Transaction History